NCT07292116Not yet recruiting
Disease Progression in ms
Prediction of Disease Progression Using Machine Learning Based on Clinical Data in People With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 18 Dec 2025
Brief summary (registry, in English)
Demographic and clinical data will be obtained from people with MS. Based on this data, the progression of the disease will be predicted with artificial intelligence.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 53 (estimated)
- First submitted
- 12 Mar 2025
- Start date
- 15 Dec 2025
- Primary completion date
- 20 Dec 2025
- Lead sponsor
- Hüseyin Bektaş
- Diseases
- Multiple sclerosis
- NCT number
- NCT07292116
What you commit to
- Study type: Observational
- Planned participants: 53
- From 15 Dec 2025 to the primary completion date, 20 Dec 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- be literate
Who the study is looking for
- Having been diagnosed with MS
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.